InsideTracker

InsideTracker is a biotechnology startup founded in 2009, with its headquarters in the United States. The company's slogan, "Live healthier longer with a personalized Action Plan, combining data from blood biomarkers, DNA, and wearables," embodies its core mission: to help individuals achieve optimal health and longevity through data-driven insights. InsideTracker's focus on personalized health analysis sets it apart, as it leverages expertise in aging, genetics, and biometric data. In its latest funding round, InsideTracker secured a $15.00M Series B investment on 08 September 2022, with participation from notable investors such as OurCrowd, Cornucopian Capital, PeakBridge Ventures, and BASF Venture Capital. This funding signifies a strong show of support for InsideTracker's innovative approach to utilizing biomarker data and AI-powered insights to empower individuals to take control of their well-being. With an intuitive mobile app, InsideTracker offers a personalized roadmap for improving health and longevity by leveraging findings from thousands of scientific peer-reviewed publications and over ten billion biomarker data points. By providing actionable recommendations backed by extensive research, InsideTracker is well-positioned to make a significant impact in the health care and analytics industries, catering to the growing demand for personalized wellness solutions.